Biphasic insulin aspart vs Gliclazide
National NHS prescribing compared (Prescription Cost Analysis)
Gliclazide was dispensed 9.7× as often as Biphasic insulin aspart in May 2026 — 462,721 items versus 47,490 in England.
47,490items
Biphasic insulin aspart · May 2026
NHSBSA Prescription Cost Analysis
462,721items
Gliclazide · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Biphasic insulin aspart versus Gliclazide: national items dispensed by month
▬ Biphasic insulin aspart · ╌ Gliclazide
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Biphasic insulin aspart | Gliclazide |
|---|---|---|
| Items, May 2026 | 47,490 | 462,721 |
| Items, last 12 months | 608,257 | 5,799,719 |
| Net ingredient cost, May 2026 | £2,235,763 | £872,639 |
See the full profile for Biphasic insulin aspart or Gliclazide.